D.E. Shaw & Co
ORGO icon

D.E. Shaw & Co’s Organogenesis Holdings ORGO Stock Holding History

D.E. Shaw & Co’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.45M Buy
2,297,974
+309,495
+16% +$1.07M ﹤0.01% 2112
2025
Q4 		$10.3M Buy
1,988,479
+1,476,843
+289% +$7.16M 0.01% 1725
2025
Q3 		$2.16M Sell
511,636
-101,423
-17% -$471K ﹤0.01% 2916
2025
Q2 		$2.24M Sell
613,059
-271,229
-31% -$1.01M ﹤0.01% 2654
2025
Q1 		$3.82M Buy
884,288
+146,845
+20% +$593K ﹤0.01% 2105
2024
Q4 		$2.36M Sell
737,443
-672
-0.1% -$2.25K ﹤0.01% 2598
2024
Q3 		$2.11M Sell
738,115
-3,818
-0.5% -$10.7K ﹤0.01% 2670
2024
Q2 		$2.08M Buy
741,933
+109,189
+17% +$293K ﹤0.01% 2624
2024
Q1 		$1.8M Sell
632,744
-334,128
-35% -$1.14M ﹤0.01% 2718
2023
Q4 		$3.95M Sell
966,872
-119,346
-11% -$334K ﹤0.01% 2100
2023
Q3 		$3.45M Sell
1,086,218
-184,747
-15% -$587K ﹤0.01% 2146
2023
Q2 		$4.22M Sell
1,270,965
-69,878
-5% -$207K ﹤0.01% 1999
2023
Q1 		$2.86M Buy
1,340,843
+909,003
+210% +$2.25M ﹤0.01% 2415
2022
Q4 		$1.16M Buy
431,840
+237,062
+122% +$692K ﹤0.01% 3331
2022
Q3 		$631K Buy
194,778
+43,523
+29% +$197K ﹤0.01% 3892
2022
Q2 		$738K Buy
151,255
+87,490
+137% +$539K ﹤0.01% 3825
2022
Q1 		$486K Sell
63,765
-12,740
-17% -$98.6K ﹤0.01% 4386
2021
Q4 		$707K Sell
76,505
-56,812
-43% -$603K ﹤0.01% 4183
2021
Q3 		$1.9M Buy
133,317
+88,723
+199% +$1.38M ﹤0.01% 3080
2021
Q2 		$741K Buy
+44,594
New +$831K ﹤0.01% 3784

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co's ORGO Position: Q1 2026 in Review

D.E. Shaw & Co increased its Organogenesis Holdings (ORGO) stake by 16% in Q1 2026, buying an estimated $1.07M and bringing the position to 2,297,974 shares worth $5.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

D.E. Shaw & Co first reported a position in ORGO in Q2 2021 and has held it in 20 quarters since. The position peaked at $10.3M in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • D.E. Shaw & Co held 2,297,974 shares of Organogenesis Holdings worth $5.45M as of Q1 2026.
  • D.E. Shaw & Co bought 309,495 Organogenesis Holdings shares in Q1 2026, an estimated $1.07M.
  • Organogenesis Holdings made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2112 holding.
  • D.E. Shaw & Co first reported a position in Organogenesis Holdings in Q2 2021 and has held it in 20 quarters since.
  • D.E. Shaw & Co's Organogenesis Holdings position peaked at $10.3M in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.